Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study.
Ther Adv Hematol
; 13: 20406207221090150, 2022.
Article
em En
| MEDLINE
| ID: mdl-35646300
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article